Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (39897)	12/18/1998 12:30:00 PM
From: wlheatmoon	Read Replies (2) \| Respond to of 132070

Just found some tidbits for why NVLS is rocketing today. Sorry POS. November chip equipment bookings show new gains- report MOUNTAIN VIEW, Calif., Dec 18 (Reuters) - The North American semiconductor equipment industry posted a further recovery in sales bookings during November but computer-chip equipment purchasing remains half where it was a year ago, a trade group said. In a statement posted on its Web site Thursday, Semiconductor Equipment and Materials International (SEMI) said November book-to-bill ratio climbed to 0.84 from 0.73 in October. A book-to-bill of 0.84 means $84 in orders were received for each $100 worth of products shipped. The monthly indicator of industry financial health bottomed in September, when the book-to-bill was 0.57. ''Technology buys are certainly going ahead as planned in the semiconductor industry,'' Stanley Myers, president of SEMI, said in the statement. ''However, keep in mind that current business levels for the equipment industry are running about half of 1997,'' he said. Myers noted that the industry is unlikely to see healthy profits return until computer chipmakers begin adding additional fabrication plant capacity, which he does not expect before the year 2000. Three-month average shipments in November 1998 were $963 million, 15 percent above October 1998's level, yet 41 percent below the November 1997 level, the trade group said. Three-month average bookings rose last month to $805 million, 29 percent above the October level, but 51 percent below the level in November of last year. The SEMI book-to-bill is a ratio of three-month moving average bookings to three-month moving average shipments and is based on data sales supplied by chip equipment making companies. Leading companies in the industry include Applied Materials Inc. (Nasdaq:AMAT - news), Novellus Systems Inc. (Nasdaq:NVLS - news), KLA-Tencor Corp. (Nasdaq:KLAC - news).

To: Knighty Tin who wrote (39897)	12/18/1998 12:34:00 PM
From: wlheatmoon	Read Replies (1) \| Respond to of 132070

A different perspective from Motley Fool Lunch time news. FOOL PLATE SPECIAL An Investment Opinion by Dale Wettlaufer Book-to-Bill Climbs Semiconductor capital equipment companies took off this morning after Semiconductor Equipment and Materials International (www.semi.com) announced its November book-to-bill ratio of 0.84 for the industry. "Technology buys are certainly going ahead as planned in the semiconductor industry," according to Stanley Myers, president of SEMI. Contrast this with "capacity buys." The difference between the two is that a technology buy is smaller purchase of equipment with next-generation technologies while a capacity buy comes from the semiconductor fabs (manufacturing facilities) increasing their supply capacity. The November book-to-bill of 0.84 is up from October's 0.75 level, but bookings were still down 51% year-over-year compared with November 1997. The market is reacting on cue, as things are falling in place across the semiconductor world. BancBoston Robertson Stephens yesterday set a three-year price target of $200 per share on DRAM producer Micron Technology (NYSE:MU - news) , which lays a red carpet into today. If a respected analytical team such as Robbie Stephens is forecasting the cash flow needed to get to a quadruple in the shares of Micron in three years, then the future must hold the promise of capacity buys for the DRAM business. What's interesting in this scenario, though, is the trader-driven and name-driven buying here. Applied Materials (Nasdaq:AMAT - news) , the class of the front-end equipment business, is up $3 11/16 to $44 13/16. But something like Electroglas (Nasdaq:EGLS - news) , one of the leading companies in chip-testing equipment, is down $1 1/8 to $11 15/16 because it is having a worse-than-expected quarter this quarter. Golly, what a surprise. Come on. If there is seriously a ramp in capacity that should be discounted here, something like Electroglas should be feeling it first. When you add capacity, you add back-end equipment first. Sure, Teradyne (NYSE:TER -news) is moving, but that's because it's liquid and it's got some good things going in other parts of the company -- specifically its backplane fabrication unit. Why aren't Cerprobe (NYSE:CPRB) , Cohu (Nasdaq:COHU - news) , and Credence Systems (Nasdaq:CMOS - news) moving? Alright, so maybe the market's inefficient. But when you see the correlation between market cap and today's moves in the names that traders and fund managers recognize, you have to wonder if the trading is correctly discounting the fundamentals. What's the most-recognized name out there? Applied. It's doing the best today. What's the most expensive company in the group? Applied. Yeah, Applied Materials is a great company, but this smacks of herd instinct, and I think some of the smart lead steers have already turned. We could be seeing the back end of the herd still going one way, not knowing that the leading market players have already stopped their buying of these names and are probablyfeeding some stock into this move. That's just my speculation. Just because the book-to-bill happens to be trending up from a highly depressed level doesn't mitigate the fact that orders and shipments across the industry are down 51% and 41%, respectively, from this time last year. Note: Since I think there are a lot of traders in these stocks, I'm sure to get a lot of opinionated notes. Just remember that the subtitle of this column is "An Investment Opinion." Like certain parts of the human anatomy, everyone's got an opinion.